Rita E Serda
Overview
Explore the profile of Rita E Serda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
964
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marwedel B, Medina L, De May H, Adogla J, Kennedy E, Flores E, et al.
Oncoimmunology
. 2024 Dec;
13(1):2421029.
PMID: 39625271
Widespread peritoneal dissemination is common in patients with gynecologic or gastrointestinal cancers. Accumulating evidence of a central role for regional immunity in cancer control indicates that intraperitoneal immunotherapy may have...
2.
Meraz I, Hearnden C, Liu X, Yang M, Williams L, Savage D, et al.
PLoS One
. 2024 Nov;
19(11):e0314577.
PMID: 39570970
[This corrects the article DOI: 10.1371/journal.pone.0094703.].
3.
Marwedel B, De May H, Anderson L, Medina L, Kennedy E, Flores E, et al.
Adv Healthc Mater
. 2024 Oct;
:e2402966.
PMID: 39478634
Intraperitoneal (IP) administration of immunogenic mesoporous silica nanoparticles (iMSN) in a mouse model of metastatic ovarian cancer promotes the development of tumor-specific CD8 T cells and protective immunity. IP delivery...
4.
Medina L, Serda R
Results Probl Cell Differ
. 2024 Sep;
73:155-171.
PMID: 39242379
Tunneling nanotubes (TNTs) are open-ended, membrane-encased extensions that connect neighboring cells. They have diameters up to 1 μm but are able to expand to convey large cargos. Lengths vary depending...
5.
Cancer Cell Silicification and Surface Functionalization to Create Microbial Mimetic Cancer Vaccines
Medina L, Kaehr B, Serda R
Methods Mol Biol
. 2023 Sep;
2720:209-219.
PMID: 37775668
As cancer progresses, tumor cells adapt to evade immune cells. To counter this, cancer cells can be silicified ex vivo, creating surface masks that can be decorated with microbial-associated molecules...
6.
Noureddine A, Marwedel B, Tang L, Medina L, Serda R
Cancers (Basel)
. 2023 Sep;
15(18).
PMID: 37760595
Immunogenic lipid-coated mesoporous silica nanoparticles (ILM) present pathogen-associated molecular patterns (PAMPs) on the nanoparticle surface to engage pathogen-associated receptors on immune cells. The mesoporous core is capable of loading additional...
7.
LaBauve A, Saada E, Jones I, Mosesso R, Noureddine A, Techel J, et al.
Sci Rep
. 2023 Apr;
13(1):6873.
PMID: 37105997
Emerging and re-emerging viral pathogens present a unique challenge for anti-viral therapeutic development. Anti-viral approaches with high flexibility and rapid production times are essential for combating these high-pandemic risk viruses....
8.
Taylor E, Wilson C, Franco S, De May H, Medina L, Yang Y, et al.
Int J Mol Sci
. 2022 Sep;
23(18).
PMID: 36142437
Current imaging approaches used to monitor tumor progression can lack the ability to distinguish true progression from pseudoprogression. Simultaneous metabolic 2-deoxy-2-[F]fluoro-D-glucose ([F]FDG) positron emission tomography (PET) and magnetic resonance imaging...
9.
Noureddine A, Paffett M, Franco S, Chan A, Pallikkuth S, Lidke K, et al.
Pharmaceutics
. 2022 Jan;
14(1).
PMID: 35056951
This study examines intra- and intercellular trafficking of mesoporous silica nanoparticles along microtubular highways, with an emphasis on intercellular bridges connecting interphase and telophase cells. The study of nanoparticle trafficking...
10.
Guo J, De May H, Franco S, Noureddine A, Tang L, Brinker C, et al.
Nat Biomed Eng
. 2021 Nov;
6(1):19-31.
PMID: 34725505
The production of personalized cancer vaccines made from autologous tumour cells could benefit from mechanisms that enhance immunogenicity. Here we show that cancer vaccines can be made via the cryogenic...